TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Allergan: Cramer's Top Takeaways
INVESTING

5 ways allergan can keep up momentum

Dow's Worst Performers: NKE, AAPL, MCD, MRK, INTC
INVESTING

These 5 stocks under $10 could make you a lot of money

Would You Meet This CEO for a 6:30 A.M. Interview?
STOCKS

Rebound may be in store for beaten-down shares of TherapeuticsMD

Insider Trading Alert - DUK, STFC And RGLS Traded By Insiders
MARKETS

OvaScience (OVAS) Weak On High Volume Today

TG Therapeutics (TGTX) Stock Slumps on Trial Amendment
MARKETS

Ovascience (OVAS) Stock Drops After Pricing Public Offering

Ovascience May Be Hard-Pressed to Overcome Market Skepticism
STOCKS

Ovascience may be hard-pressed to overcome market skepticism

Energy Transfer Equity (ETE) Is Today's Dead Cat Bounce Stock
MARKETS

OvaScience (OVAS) Is Strong On High Volume Today

Rogue Traders Whose Behavior Is Risky Can Be Tracked Early On
OPINION

Insiders at these 5 companies are scooping up shares of their own stock.

Credit Suisse's 12 Contrarian Stock Ideas to Sell Now
STOCKS

Credit Suisse is even more pessimistic than Wall Street on these 12 stocks. Sell them now.

Dow Ends Above 28,000; Stocks at Records on Trade-Deal Hopes
OPINION

5 stocks insiders love right now

5 Things You Must Know Before the Market Opens Friday
OPINION

5 stocks under $10 set to soar

7 Public Companies That Are Literally Changing People’s Lives
TECHNOLOGY

7 Public Companies That Are Literally Changing People’s Lives

Furniture Retailer Wayfair Shares Tank on Amazon Program
OPINION

5 Stocks Poised for Breakouts

Pearson Plummets on Lower Guidance; Other Publishers Offer Better Investment Opportunities
STOCKS

The Numbers Behind Biotech's Horrible, No Good, Awful August

'Mad Money' Lightning Round: Energy Transfer Partners Is Going Higher
JIM CRAMER

'Mad Money' Lightning Round: Dominion Resources the Best-Run Utility

Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Six Winning Earnings Themes

Drug Giant Eli Lilly Wants to Save Money So it Brought in These New Bigwigs
STOCKS

Blame Keryx Executives, Not Short Sellers, for Dismal Drug Launch, Sinking Stock

Just What Jittery U.S. Markets Don't Need -- More Global Growth Worries
INVESTING

4 Stocks Spiking on Big Volume

Citi Joins Peers In Downgrading Tiffany On Pessimism About Near-Term Trends
INVESTING

4 Big-Volume Stocks to Trade for Breakouts

Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Biotech Stock Mailbag: Breaking the Feuerstein-Ratain Rule; Medical Conferences; Celgene

'Mad Money' Lightning Round: Buy, Buy, Buy CBS When Stock Comes Down
JIM CRAMER

'Mad Money' Lightning Round: Ambarella Is Like Putting a Gun to Your Head

Cramer: $45 a Barrel Oil Is a 'Must-Hold' Level for Many Producers
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Zombie Stocks That Will Rise From the Dead

5 Stocks Poised for Breakouts: Twitter, Apple and More
INVESTING

5 Stocks Poised for Breakouts: Twitter, Apple and More

5 Stocks Insiders Love Right Now: eHealth, Worthington Industries and More
INVESTING

5 Stocks Insiders Love Right Now: eHealth, Worthington Industries and More

Avoid the Market Carnage With These 5 Big Stocks
STOCKS

Biotech Investors' Guide and Preview to J.P. Morgan Healthcare Conference: Part 2